Active Ingredient (In Each Patch)
Retatrutide 1.6 mg ……………………………. Weight management / blood sugar control
The following Structured Product Label (SPL) was submitted to the FDA by Guangzhou Yixin Cross-border E-commerce Co., Ltd. for the product Esokalli Slimming Microcrystalline Patch (NDC 84778-078). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each patch), purpose, uses, warnings, dosage and administration, do not use if you, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Retatrutide 1.6 mg ……………………………. Weight management / blood sugar control
Weight loss aid
Improves blood sugar control (when used with diet and exercise)
To support weight management
To improve glycemic control in adults with type 2 diabetes mellitus
Provides long-acting sustained-release delivery via soluble microneedle patch
For external use only
For external use only.
have type 1 diabetes
need treatment for diabetic ketoacidosis
are pregnant or breastfeeding
are under 18 years of age
monitor blood glucose regularly
possible side effects include:
hypoglycemia
nausea, vomiting, or diarrhea
acute pancreatitis
complications of diabetic retinopathy
increased heart rate
hypersensitivity or allergic reactions
• you develop severe abdominal pain (possible acute pancreatitis)
• symptoms of hypersensitivity occur (rash, swelling, difficulty breathing)
• persistent gastrointestinal problems occur
In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
Microcrystalline matrix, soluble microneedle polymer blend, stabilizers, adhesive layer.
* Please review the disclaimer below.